3-MeO-PCP

3-MeO-PCP
Clinical data
ATC code	None;
Legal status
Legal status	BR: Class F2 (Prohibited psychotropics); CA: Schedule I; DE: Anlage II (Authorized trade only, not prescriptible); UK: Class B; UN: Psychotropic Schedule II; Illegal in the Czech Republic and Sweden;
Identifiers
	IUPAC name 1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine;
CAS Number	72242-03-6 ; 91164-58-8 (hydrochloride);
PubChem CID	11778080;
ChemSpider	9952762 ;
UNII	28A91R606X;
KEGG	C22809 ;
CompTox Dashboard (EPA)	DTXSID50222578 ;
Chemical and physical data
Formula	C18H27NO
Molar mass	273.420 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES COc3cccc(c3)C1(CCCCC1)N2CCCCC2;
	InChI InChI=1S/C18H27NO/c1-20-17-10-8-9-16(15-17)18(11-4-2-5-12-18)19-13-6-3-7-14-19/h8-10,15H,2-7,11-14H2,1H3 ; Key:BQQSZHHKGPOXLN-UHFFFAOYSA-N ;
	(what is this?) (verify)

3-Methoxyphencyclidine (3-MeO-PCP) is a dissociative hallucinogen of the arylcyclohexylamine class related to phencyclidine (PCP) which has been sold online as a designer drug. It has been used across Europe and the United States. In some cases, consumption has been known to be fatal. It acts mainly as an NMDA receptor antagonist, though it has also been found to interact with the sigma σ₁ receptor and the serotonin transporter. The drug does not possess any opioid activity nor does it act as a dopamine reuptake inhibitor.